1.

Record Nr.

UNINA9910297054303321

Autore

Yang Qinghua

Titolo

Aegis or Achilles heel : the dilemma of homololy in biopatents in the wake of novozymes / / Qinghua Yang

Pubbl/distr/stampa

Nomos Verlagsgesellschaft mbH & Co. KG, 2018

Baden-Baden, Germany : , : Nomos Verlagsgesellschaft mbH, , 2018

ISBN

3-8452-9271-7

Edizione

[First edition.]

Descrizione fisica

1 online resource (72 pages)

Collana

Munich Intellectual Property Law Center – MIPLC

Disciplina

346.0486

Soggetti

Biotechnology

Patent laws and legislation

Lingua di pubblicazione

Inglese

Formato

Materiale a stampa

Livello bibliografico

Monografia

Nota di bibliografia

Includes bibliographical references.

Sommario/riassunto

Biopatents frequently disclose sequences of polypeptides and nucleic acids in the written description. The claims often cover a homology range surrounding the disclosed sequence to get a broader protection. However, homology claims face a hurdle that they may lack support by the written description. The Supreme Court of China ruled that homology claims lack support, but a further limitation by species of origin satisfies this requirement. This study explains that homology per se should have formed the essence of such disputes. Homology dictates the skilled person’s confidence on the functionality of unknown sequences, and is involved in multiple patentability requirements. Thus, the assessment of support is not an isolated matter. Disparity of different requirements creates an unclaimable gap, and constitutes a discrimination to biotechnology. An appropriate test for the support requirement is thus furnished to confer a scope of protection commensurating to the technical contribution.